Analysts have identified the First Trust Small Cap Core AlphaDEX Fund ETF (FYX) as having a 12.46% upside potential based on its underlying holdings. Three of FYX’s holdings with notable upside are Harrow Inc (HROW), Travere Therapeutics Inc (TVTX), and Omnicell Inc (OMCL). HROW has a 56.48% upside, TVTX has a 53.10% upside, and OMCL has a 39.49% upside to their analyst target prices. Analysts may be optimistic about these targets, but further research is needed to determine if they are justified. For more information on ETFs with potential upside, visit the ETF Channel website.

Read more at Nasdaq: Implied FYX Analyst Target Price: $122